135 related articles for article (PubMed ID: 36343749)
1. Major Bleeding During Thrombolytic Therapy for Acute Lower Limb Ischaemia: Value of Laboratory Tests for Clinical Decision Making, 17 Years of Experience.
Doelare SAN; Oukrich S; Ergin K; Jongkind V; Wiersema AM; Lely RJ; Ebben HP; Yeung KK; Hoksbergen AWJ;
Eur J Vasc Endovasc Surg; 2023 Mar; 65(3):398-404. PubMed ID: 36343749
[TBL] [Abstract][Full Text] [Related]
2. Short-Term Complications and Outcomes in Pharmaco-Mechanical Thrombolysis First and Catheter-Directed Thrombolysis First in Patients with Acute Lower Limb Ischemia.
Acosta S; Karonen E; Eek F; Butt T
Ann Vasc Surg; 2023 Aug; 94():253-262. PubMed ID: 36868462
[TBL] [Abstract][Full Text] [Related]
3. Catheter-directed thrombolysis for acute limb ischemia caused by native artery occlusion: an experience of a university hospital.
Wongwanit C; Hahtapornsawan S; Chinsakchai K; Sermsathanasawadi N; Hongku K; Ruangsetakit C; Mutirangura P
J Med Assoc Thai; 2013 Jun; 96(6):661-8. PubMed ID: 23951822
[TBL] [Abstract][Full Text] [Related]
4. Catheter Directed Thrombolysis for Not Immediately Threatening Acute Limb Ischaemia: Systematic Review and Meta-Analysis.
Doelare SAN; Koedam TWA; Ebben HP; Tournoij E; Hoksbergen AWJ; Yeung KK; Jongkind V;
Eur J Vasc Endovasc Surg; 2023 Apr; 65(4):537-545. PubMed ID: 36608784
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous thrombectomy or ultrasound-accelerated thrombolysis for initial management of acute limb ischaemia.
Araujo ST; Moreno DH; Cacione DG
Cochrane Database Syst Rev; 2022 Jan; 1(1):CD013486. PubMed ID: 34981833
[TBL] [Abstract][Full Text] [Related]
6. Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis.
Skeik N; Gits CC; Ehrenwald E; Cragg AH
Vasc Endovascular Surg; 2013 Oct; 47(7):519-23. PubMed ID: 23899656
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity in Standard Operating Procedures for Catheter Directed Thrombolysis for Peripheral Arterial Occlusions in The Netherlands: A Nationwide Overview.
Leenstra BS; van Ginkel DJ; Hazenberg CEVB; Vonken EPA; de Borst GJ
Eur J Vasc Endovasc Surg; 2019 Oct; 58(4):564-569. PubMed ID: 31383585
[TBL] [Abstract][Full Text] [Related]
8. Contemporary outcomes of endovascular interventions for acute limb ischemia.
Byrne RM; Taha AG; Avgerinos E; Marone LK; Makaroun MS; Chaer RA
J Vasc Surg; 2014 Apr; 59(4):988-95. PubMed ID: 24360240
[TBL] [Abstract][Full Text] [Related]
9. Predictors of bleeding complications during catHeter-dirEcted thrombolysis for peripheral arterial occlusions (POCHET).
Mol BM; Verwer MC; Fijnheer R; Florie J; Groot OA; Hietbrink F; Nijkeuter M; Vonken EPA; van Weel V; de Kleijn DPV; de Borst GJ;
PLoS One; 2024; 19(5):e0302830. PubMed ID: 38722842
[TBL] [Abstract][Full Text] [Related]
10. Ultrasound-accelerated versus standard catheter-directed thrombolysis in 102 patients with acute and subacute limb ischemia.
Schernthaner MB; Samuels S; Biegler P; Benenati JF; Uthoff H
J Vasc Interv Radiol; 2014 Aug; 25(8):1149-56; quiz 1157. PubMed ID: 24933285
[TBL] [Abstract][Full Text] [Related]
11. Fibrinogen Level and Bleeding Risk During Catheter-Directed Thrombolysis Using Tissue Plasminogen Activator.
Lee K; Istl A; Dubois L; DeRose G; Forbes TL; Wiseman D; Mujoomdar A; Kribs S; Power AH
Vasc Endovascular Surg; 2015 Oct; 49(7):175-9. PubMed ID: 26462979
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound-Assisted Catheter-Directed Thrombolysis for Submassive Pulmonary Embolism.
Mohan PP; Manov JJ; Contreras F; Langston ME; Doshi MH; Narayanan G
Vasc Endovascular Surg; 2018 Apr; 52(3):195-201. PubMed ID: 29436310
[TBL] [Abstract][Full Text] [Related]
13. Prourokinase versus urokinase for recanalization of peripheral occlusions, safety and efficacy: the PURPOSE trial.
Ouriel K; Kandarpa K; Schuerr DM; Hultquist M; Hodkinson G; Wallin B
J Vasc Interv Radiol; 1999 Sep; 10(8):1083-91. PubMed ID: 10496712
[TBL] [Abstract][Full Text] [Related]
14. Ultrasound-accelerated thrombolysis in arterial and venous peripheral occlusions: fibrinogen level effects.
Raabe RD
J Vasc Interv Radiol; 2010 Aug; 21(8):1165-72. PubMed ID: 20656221
[TBL] [Abstract][Full Text] [Related]
15. Plasma Fibrinogen Change as a Predictor of Major Bleeding During Catheter-Directed Thrombolysis.
Dorey T; Kong D; Lobo W; Hanlon E; Abramowitz S; Turcotte J; Jeyabalan G
Ann Vasc Surg; 2024 Feb; 99():262-271. PubMed ID: 37802144
[TBL] [Abstract][Full Text] [Related]
16. Complications associated with the use of urokinase and recombinant tissue plasminogen activator for catheter-directed peripheral arterial and venous thrombolysis.
Ouriel K; Gray B; Clair DG; Olin J
J Vasc Interv Radiol; 2000 Mar; 11(3):295-8. PubMed ID: 10735422
[TBL] [Abstract][Full Text] [Related]
17. Low-dose thrombolysis for thromboembolic lower extremity arterial occlusions is effective without major hemorrhagic complications.
Ebben HP; Nederhoed JH; Lely RJ; Meijerink MR; van der Meijs BB; Wisselink W; Yeung KK; Hoksbergen AW
Eur J Vasc Endovasc Surg; 2014 Nov; 48(5):551-8. PubMed ID: 25108710
[TBL] [Abstract][Full Text] [Related]
18. Catheter Directed Thrombolysis Protocols for Peripheral Arterial Occlusions: a Systematic Review.
Ebben HP; Jongkind V; Wisselink W; Hoksbergen AWJ; Yeung KK
Eur J Vasc Endovasc Surg; 2019 May; 57(5):667-675. PubMed ID: 31005512
[TBL] [Abstract][Full Text] [Related]
19. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial.
Ann Surg; 1994 Sep; 220(3):251-66; discussion 266-8. PubMed ID: 8092895
[TBL] [Abstract][Full Text] [Related]
20. Thrombolysis of acute peripheral arterial and venous occlusions with tenecteplase and eptifibatide: a pilot study.
Burkart DJ; Borsa JJ; Anthony JP; Thurlo SR
J Vasc Interv Radiol; 2003 Jun; 14(6):729-33. PubMed ID: 12817039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
